The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Good morning,
Ottawa is planning with a U.S. pharmaceutical giant to finance the expansion of its Winnipeg plant, which already has the technology to do the final stages of production for several types of vaccines. That includes the highly sought-after mRNA COVID-19 vaccines.
Industry Minister François-Philippe Champagne said the federal government plans to help Emergent BioSolutions expand its production capacity so that it can attract some major COVID-19 vaccine players that Canada has contracts with. Even though this won’t have an impact on the current vaccination rollout in Canada, it could bring more reliability to future vaccination campaigns.